Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Myriad Genetics (MYGN) over the last 16 years, with Dec 2024 value amounting to -$127.3 million.

  • Myriad Genetics' Net Income towards Common Stockholders fell 23.98% to -$27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$400.5 million, marking a year-over-year decrease of 245.26%. This contributed to the annual value of -$127.3 million for FY2024, which is 51.65% up from last year.
  • Per Myriad Genetics' latest filing, its Net Income towards Common Stockholders stood at -$127.3 million for FY2024, which was up 51.65% from -$263.3 million recorded in FY2023.
  • Myriad Genetics' Net Income towards Common Stockholders' 5-year high stood at -$27.2 million during FY2021, with a 5-year trough of -$263.3 million in FY2023.
  • Its 3-year average for Net Income towards Common Stockholders is -$167.5 million, with a median of -$127.3 million in 2024.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 6,337.50% in 2020, then surged by 87.84% in 2021.
  • Yearly analysis of 5 years shows Myriad Genetics' Net Income towards Common Stockholders stood at -$199.6 million in 2020, then reached -$223.7 million in 2020, then skyrocketed by 87.84% to -$27.2 million in 2021, then crashed by 311.76% to -$112.0 million in 2022, then crashed by 135.09% to -$263.3 million in 2023, then surged by 51.65% to -$127.3 million in 2024.